Member Exclusive

CRISPR-Cas9 gene-editing: can it be used to identify therapeutic targets for ALS?

Genome-wide gene-knockout screens using CRISPR-Cas9 could allow researchers to identify potential drug targets for amyotrophic lateral sclerosis and other neurodegenerative diseases.

Go to the profile of Hannah Makin
Mar 09, 2018

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.